MedTrace Logo

Malnutrition and Sarcopenia Screening in Chemotherapy Patients

NCT07163286 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-09-09

No results posted yet for this study

Summary

The study will include approximately 150 adult outpatients diagnosed with solid tumors who are currently receiving chemotherapy. Both early and advanced stage patients of any sex aged 18 and older will be included, provided they are clinically stable and able to participate in the assessments.

Conditions

  • Nutrition Aspect of Cancer
  • Sarcopenia
  • Chemotherapeutic Agent Toxicity

Sponsors & Collaborators

  • Çanakkale Onsekiz Mart University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2025-12-31
Completion
2026-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07163286 on ClinicalTrials.gov